Phase 3 Leukaemia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with primary acute myeloid leukaemia (AML), confirmed through bone marrow testing
- People aged between 18 and 75 years old
- People whose liver and kidney function test results fall within acceptable ranges as defined by the trial
- People whose heart function shows a pumping efficiency of at least 50%, with heart marker blood tests also within acceptable ranges
- People who are generally able to carry out basic daily activities, rated as 0–2 on a standard physical wellbeing scale used by doctors
- People who have given their written consent to participate, either personally or through a family member
Who may not be able to join:
- People who have a known allergy or medical reason to avoid any of the medications used in this trial
- People who also have a condition called myelofibrosis (scarring of the bone marrow)
- People with serious heart conditions, including previous heart attack or heart failure
- People who have another type of cancer affecting a different part of the body
- People who have active tuberculosis or who are HIV-positive
- People who have another blood disorder at the same time as their AML diagnosis
- People who are pregnant or currently breastfeeding
- People who are unable to understand or follow the trial's instructions and requirements
- People who have previously had a serious reaction or intolerance to medications similar to those used in this trial
- People who are currently taking part in another clinical trial
- People with any other condition that the trial team determines would prevent safe participation (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Fuling Zhou, Wuhan University
Phone: 027-67813137
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Complete remission rate
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.